Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-20T04:28:27.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T00:47:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T20:30:05.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T15:12:15.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T02:20:19.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study aims and inclusion/exclusion criteria for a clinical trial, while retaining the name of the principal investigator and collaborators.
    Difference
    16%
    Check dated 2025-04-16T14:20:41.000Z thumbnail image

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.